Retatrutide (RT20) is a novel synthetic modified peptide, with the research code LY3437943. It belongs to the triple receptor agonist class, and research focuses primarily on metabolic regulation, receptor signaling pathways, and energy balance.
Retatrutide RT20 is a synthetic lipidated peptide research compound (LY3437943), designed as a triple receptor agonist targeting GLP-1R, GIPR, and glucagon receptor pathways. It is a 39-amino-acid modified peptide supplied as a white lyophilized powder for laboratory research applications.
Retatrutide (RT20 / LY3437943) is a synthetic lipidated peptide research compound primarily used in metabolic and peptide pharmacology studies. As a triple receptor agonist targeting GLP-1R, GIPR, and GCGR pathways, it is investigated for receptor signaling mechanisms, energy metabolism, glucose metabolism, lipid metabolism, peptide engineering, and pharmacokinetic research. Retatrutide serves as a valuable research tool for exploring multi-pathway metabolic regulation and the development of next-generation peptide-based compounds.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Retatrutide (RT10) is a synthetic peptide research compound designed as a triple...
Retatrutide RT30 is a 30mg research-grade peptide product of Retatrutide (LY3437...
TR10 (Tirzepatide) is a dual receptor agonist research peptide used for metaboli...
Contact our team for volume discounts and custom peptide services
Weitai Bio is a national high-tech enterprise specializing in the research, development, production, and sales of peptide drugs. It is also a leading global supplier of high-quality peptides, consistently focusing on peptide drugs and small nucleic acid fields.